Chesapeake Mobile App Cross Platform Development
BASIC
- Around 5 Screens.
- Around 5 Integrations
- Only simple validations on device
- No-obligation inquiry.
- Team consists of: Dev Team - 1 Developer (full time) QA Team - 1 Test Engineer (shared)
STANDARD
- Around 10 Screens
- Around 10 Integrations
- Simple business logic for Validations / Calculations / Chart Data etc.
- Some local storage of data
- Team consists of: Dev Team - 1 Developer (full time) QA Team - 1 Test Engineer (shared)
- 1 Project Manager (shared)
- 1 Team Lead (shared)
PREMIUM
- Around 20 Screens
- Around 20 Integrations
- Complex business logic like Interactive Charts, Animations, Validations, Conditions etc.
- Complete local storage of data used by App
- We will create suggestions on monthly basis for improvement for you.
Cross-Platform App Development Services & Solutions in Chesapeake
We take your groundwork and create a market-ready app based on your needs while you focus on product and company growth.
Flutter is the fastest-growing cross-platform development framework. It was introduced in 2017 by Google and managed to gain great popularity among cross-platform programmers.
Chesapeake News
Record-breaking investment in Virginia farmers' conservation practices
The Virginia Agricultural Best Management Practices Cost-Share Program received 3 million and will help farmers to implement best conservation practices.
South River High’s underwater robot deployed in search for oyster reef data
The South River High School robotics team deployed a robot into the South River Wednesday to collect data from an oyster reef.
Crisfield flood plan among many endangered programs with Maryland in 'unchartered waters'
The low-lying coastal community of Crisfield lost a federal grant aimed at preventing flooding and managing sea-level rise, in wide-ranging cuts.
Juul gets FDA’s OK to keep selling tobacco and menthol e-cigarettes
In recent years, the FDA has authorized a handful of e-cigarettes to help adult smokers cut back on cigarettes. Juul’s main competitors, Vuse and Njoy, each previously received FDA permission to ...

